Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
cancer
100%
radiotherapy
58%
tumors
55%
radiations
33%
patients
21%
clostridium
21%
humans
21%
mitochondria
21%
mice
20%
lungs
20%
genes
19%
comparative evaluations
19%
tissues
19%
metabolism
19%
applications
19%
control
17%
lung cells
17%
therapy
16%
breasts
16%
hypoxia
15%
immunotherapy
14%
irradiation
13%
proteins
13%
in vivo
12%
levels
11%
mass spectrometry
11%
lymphopenia
11%
doses
11%
bacteria
10%
esters
10%
lipids
9%
fatty acids
9%
in vitro
9%
polyphenols
9%
biological markers
9%
tools
9%
x radiation
8%
respiration
8%
liver
8%
inflammation
8%
spheroids
8%
glycine
8%
serine
8%
clostridium butyricum
8%
probability
8%
regulations
8%
gene recombination
8%
diet
8%
tumor cells
7%
oxygen
7%
data
7%
clinical trials
7%
plasmids
6%
genetics
6%
animals
6%
strains
6%
diseases
6%
dna damages
6%
dna
6%
viability
6%
delivery
6%
chains
6%
modifications
5%
vectors
5%
computed tomography
5%
apoptosis
5%
radiosensitizers
5%
efficiency
5%
learning
5%
antigens
5%
cloning
5%
computerized tomography
5%
interventions
5%
capacity
5%
radioresistance
5%
Keyphrases
Radiotherapy
22%
Clostridium
17%
Radiotherapy Response
12%
Non-small Cell Lung Cancer (NSCLC)
12%
Clostridium Sporogenes
8%
Cancer Treatment
8%
Mitochondrial Respiration
8%
Glycine Metabolism
8%
Cas9 Protein
8%
Oncology
8%
Clostridium Butyricum
8%
Radiation-induced Lymphopenia
8%
Caffeic Acid Phenethyl Ester
8%
Irradiation
8%
Therapeutic Efficacy
8%
Tumor
7%
Therapeutic Window
6%
Gene Editing
6%
Genetic Engineering
6%
Cancer Immunotherapy
6%
Xenograft
5%
Radiosensitization
5%
Genome Editing
5%
Hypoxia
5%
Cancer Therapy
5%
European Society
5%
HepG2 Cells
5%
Cancer Diagnosis
5%
Tumor Microenvironment
5%
Radiation Oncology
5%
Lung Cancer Treatment
5%
Radiotherapy-induced
5%
Medicine and Dentistry
Radiation Therapy
31%
Neoplasm
19%
Mitochondrial Respiration
12%
Lung Cancer
10%
Malignant Neoplasm
10%
Hypoxia
9%
Non Small Cell Lung Cancer
9%
Polyphenol
9%
Clostridium
8%
Caffeic Acid Phenethyl Ester
8%
Breast Cancer
8%
Treatment Response
8%
Tumor Cell
8%
Cancer Therapy
7%
Xenograft
6%
Therapeutic Window
6%
Clinical Trial
5%
Tumor Xenograft
5%
Adverse Effect
5%
In Vitro
5%
Oncology
5%